Delayed hypersensitivity reactions caused by iodixanol: An assessment of cross-reactivity in 22 patients - 30/11/11
Doi : 10.1016/j.jaci.2011.05.034
Frédéric Hasdenteufel, PharmD a 
, Julie Waton, MD b, Vanina Cordebar, MD a, Myriam Studer, MD b, Olivier Collignon, PhD c, Samuel Luyasu, MD a, Etienne Beaudouin, MD a, Jean-Marie Renaudin, MD a, Martine Morisset, MD, PhD a, Gisèle Kanny, MD, PhD a, Annick Barbaud, MD, PhD b
, Julie Waton, MD b, Vanina Cordebar, MD a, Myriam Studer, MD b, Olivier Collignon, PhD c, Samuel Luyasu, MD a, Etienne Beaudouin, MD a, Jean-Marie Renaudin, MD a, Martine Morisset, MD, PhD a, Gisèle Kanny, MD, PhD a, Annick Barbaud, MD, PhD b a EA 3999 “Allergy Diseases: Diagnosis & Therapeutics,” Department of Internal Medicine, Clinical Immunology and Allergology, University Hospital of Nancy, Nancy, France
b Department of Dermatology, University Hospital of Nancy, Nancy, France
c Genclis S.A.S., Vandoeuvre-lès-Nancy, France
| Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest. |
© 2011
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 128 - N° 6
P. 1356-1357 - décembre 2011 Retour au numéro
Article précédent
- Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies
- Soumya D. Chakravarty, Arthur F. Yee, Stephen A. Paget
- Predisposition to the development of IL-9–secreting T cells in atopic infants
- Weiguo Yao, Robert S. Tepper, Mark H. Kaplan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?